ADUS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Addus HomeCare Corp (ADUS) is not a strong buy at the moment for a beginner investor with a long-term focus. While the company has demonstrated strong financial growth in the latest quarter, the technical indicators and trading sentiment suggest a lack of immediate upside potential. Insider selling and mixed analyst ratings further dampen the investment case. Holding off for now and monitoring the stock for better entry points may be more prudent.
The MACD is negative and expanding, indicating a bearish trend. RSI is at 32.156, which is neutral but approaching oversold territory. Moving averages are converging, suggesting indecision in price movement. The stock is trading near its S1 support level of 103.751, with resistance at 110.331.
The company reported strong Q4 2025 financials, with revenue up 25.55% YoY and net income up 52.52% YoY. EPS also increased by 50.47%, reflecting strong demand in the home care sector.
Insiders have been selling shares significantly, with a 15738.20% increase in selling activity over the last month. Analyst ratings are mixed, with some lowering price targets. The MACD and other technical indicators suggest bearish momentum.
In Q4 2025, Addus HomeCare reported revenue of $373.1 million, up 25.55% YoY. Net income increased by 52.52% YoY to $29.78 million. EPS grew by 50.47% to $1.61. However, gross margin dropped to 32.02%, down 3.18% YoY.
Analysts have mixed views. Stephens lowered the price target to $135 but maintained an Overweight rating. Barclays lowered the price target to $112 and maintained an Underweight rating. Truist initiated coverage with a Buy rating and a $135 price target, citing strong earnings potential and market opportunities.
